Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced that the U.S. Food and Drug Administration (FDA) has granted...
CVS Health®, announced that it has launched Cordavis, a wholly owned subsidiary that will work directly with manufacturers to commercialize and/or co-produce biosimilar products (an...
Welldoc®, a digital health leader revolutionizing chronic care, announced the receipt of its 11th 510(k) clearance from the Food and Drug Administration (FDA) for its...
Artiva Biotherapeutics, Inc., a clinical stage company whose mission is to deliver highly effective, off-the-shelf, allogeneic natural killer (NK) cell-based therapies, announced that the...
Tempus, a leader in artificial intelligence and precision medicine, announced that the U.S. Food & Drug Administration (FDA) has granted the company Breakthrough Device...
